Table 2.
Tumor response, n (%) | All patients (n = 133) | Training set (n = 93) | Validation set (n = 40) |
---|---|---|---|
Complete response (CR) | 1 (0.8) | 1 (1.1) | 0 |
Partial response (PR) | 30 (22.6) | 19 (20.4) | 11 (27.5) |
Stable disease (SD) | 65 (48.9) | 46 (49.5) | 19 (47.5) |
Progressive disease (PD) | 37 (27.8) | 27 (29.0) | 10 (25.0) |
ORR (CR + PR)* | 31 (23.4) | 20 (21.5) | 11 (27.5) |
DCR (CR + PR + SD)# | 96 (72.2) | 66 (71.0) | 30 (75.0) |
DCR, disease control rate; ORR, objective response rate.
*Pearson χ² = 0.562, P = 0.453 (ORR comparison between the validation and training sets).
#Pearson χ² = 0.226, P = 0.634 (DCR comparison between the validation and training sets).